Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
PSIX vs DCGO
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
PSIX vs DCGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Medical - Care Facilities |
| Market Cap | $1.72B | $61M |
| Revenue (TTM) | $531M | $330M |
| Net Income (TTM) | $114M | $-182.40T |
| Gross Margin | 34.8% | 30.7% |
| Operating Margin | 20.7% | -55.3% |
| Forward P/E | 15.6x | — |
| Total Debt | $152M | $29.18T |
| Cash & Equiv. | $41M | $52.48T |
PSIX vs DCGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Power Solutions Int… (PSIX) | 100 | 2257.3 | +2157.3% |
| DocGo Inc. (DCGO) | 100 | 6.1 | -93.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PSIX vs DCGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PSIX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 5.8% 10Y total return vs DCGO's -94.0%
- 21.5% margin vs DCGO's -56.6%
- +182.4% vs DCGO's -73.4%
DCGO is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 2.27
- Rev growth 523K%, EPS growth -11.2%, 3Y rev CAGR 89.1%
- Lower volatility, beta 2.27, Low D/E 23.2%, current ratio 2.26x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 523K% revenue growth vs PSIX's -100.0% | |
| Quality / Margins | 21.5% margin vs DCGO's -56.6% | |
| Stability / Safety | Beta 2.27 vs PSIX's 3.33, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +182.4% vs DCGO's -73.4% | |
| Efficiency (ROA) | 26.9% ROA vs DCGO's -336.1%, ROIC 36.9% vs -260.4% |
PSIX vs DCGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PSIX vs DCGO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PSIX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PSIX is the larger business by revenue, generating $531M annually — 1.6x DCGO's $330M. PSIX is the more profitable business, keeping 21.5% of every revenue dollar as net income compared to DCGO's -56.6%. On growth, DCGO holds the edge at +999999.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $531M | $330M |
| EBITDAEarnings before interest/tax | $115M | -$174.09T |
| Net IncomeAfter-tax profit | $114M | -$182.40T |
| Free Cash FlowCash after capex | $4M | $19.47T |
| Gross MarginGross profit ÷ Revenue | +34.8% | +30.7% |
| Operating MarginEBIT ÷ Revenue | +20.7% | -55.3% |
| Net MarginNet income ÷ Revenue | +21.5% | -56.6% |
| FCF MarginFCF ÷ Revenue | +0.8% | +6.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +999999.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -30.7% | -41.8% |
Valuation Metrics
DCGO leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.7B | $61M |
| Enterprise ValueMkt cap + debt − cash | $1.8B | -$23.31T |
| Trailing P/EPrice ÷ TTM EPS | 15.08x | -0.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.64x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 15.88x | — |
| Price / SalesMarket cap ÷ Revenue | — | 0.00x |
| Price / BookPrice ÷ Book value/share | 9.62x | 0.00x |
| Price / FCFMarket cap ÷ FCF | 121.38x | 0.00x |
Profitability & Efficiency
PSIX leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
PSIX delivers a 81.3% return on equity — every $100 of shareholder capital generates $81 in annual profit, vs $-6 for DCGO. DCGO carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to PSIX's 0.85x. On the Piotroski fundamental quality scale (0–9), PSIX scores 5/9 vs DCGO's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +81.3% | -5.8% |
| ROA (TTM)Return on assets | +26.9% | -3.4% |
| ROICReturn on invested capital | +36.9% | -2.6% |
| ROCEReturn on capital employed | +50.7% | -2.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.85x | 0.23x |
| Net DebtTotal debt minus cash | $111M | -$23.31T |
| Cash & Equiv.Liquid assets | $41M | $52.48T |
| Total DebtShort + long-term debt | $152M | $29.18T |
| Interest CoverageEBIT ÷ Interest expense | 13.09x | — |
Total Returns (Dividends Reinvested)
PSIX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PSIX five years ago would be worth $121,122 today (with dividends reinvested), compared to $627 for DCGO. Over the past 12 months, PSIX leads with a +182.4% total return vs DCGO's -73.4%. The 3-year compound annual growth rate (CAGR) favors PSIX at 193.4% vs DCGO's -58.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.1% | -30.0% |
| 1-Year ReturnPast 12 months | +182.4% | -73.4% |
| 3-Year ReturnCumulative with dividends | +2425.1% | -92.6% |
| 5-Year ReturnCumulative with dividends | +1111.2% | -93.7% |
| 10-Year ReturnCumulative with dividends | +575.3% | -94.0% |
| CAGR (3Y)Annualised 3-year return | +193.4% | -58.1% |
Risk & Volatility
Evenly matched — PSIX and DCGO each lead in 1 of 2 comparable metrics.
Risk & Volatility
DCGO is the less volatile stock with a 2.27 beta — it tends to amplify market swings less than PSIX's 3.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PSIX currently trades 61.2% from its 52-week high vs DCGO's 25.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.33x | 2.27x |
| 52-Week HighHighest price in past year | $121.78 | $2.45 |
| 52-Week LowLowest price in past year | $25.09 | $0.49 |
| % of 52W HighCurrent price vs 52-week peak | +61.2% | +25.4% |
| RSI (14)Momentum oscillator 0–100 | 46.9 | 53.3 |
| Avg Volume (50D)Average daily shares traded | 621K | 1.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $104.26 | — |
| # AnalystsCovering analysts | 6 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
PSIX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DCGO leads in 1 (Valuation Metrics). 1 tied.
PSIX vs DCGO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is PSIX or DCGO a better buy right now?
For growth investors, DocGo Inc.
(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus -100. 0% for Power Solutions International, Inc. (PSIX). Power Solutions International, Inc. (PSIX) offers the better valuation at 15. 1x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Power Solutions International, Inc. (PSIX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PSIX or DCGO?
Over the past 5 years, Power Solutions International, Inc.
(PSIX) delivered a total return of +1111%, compared to -93. 7% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: PSIX returned +575. 3% versus DCGO's -94. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PSIX or DCGO?
By beta (market sensitivity over 5 years), DocGo Inc.
(DCGO) is the lower-risk stock at 2. 27β versus Power Solutions International, Inc. 's 3. 33β — meaning PSIX is approximately 47% more volatile than DCGO relative to the S&P 500. On balance sheet safety, DocGo Inc. (DCGO) carries a lower debt/equity ratio of 23% versus 85% for Power Solutions International, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — PSIX or DCGO?
By revenue growth (latest reported year), DocGo Inc.
(DCGO) is pulling ahead at 522574% versus -100. 0% for Power Solutions International, Inc. (PSIX). On earnings-per-share growth, the picture is similar: Power Solutions International, Inc. grew EPS 64. 1% year-over-year, compared to -1122. 2% for DocGo Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — PSIX or DCGO?
Power Solutions International, Inc.
(PSIX) is the more profitable company, earning 21. 5% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 21. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PSIX leads at 20. 7% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — PSIX leads at 34. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — PSIX or DCGO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is PSIX or DCGO better for a retirement portfolio?
For long-horizon retirement investors, Power Solutions International, Inc.
(PSIX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+575. 3% 10Y return). DocGo Inc. (DCGO) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PSIX: +575. 3%, DCGO: -94. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between PSIX and DCGO?
These companies operate in different sectors (PSIX (Industrials) and DCGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PSIX is a small-cap deep-value stock; DCGO is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.